A federal grand jury's price fixing charges against Ara Aprahamian, a former generic pharma executive, are based on discussions he had with cooperating witnesses at an unnamed competitor firm. While the indictment does not name Aprahmian's former company, it is clear from the details provided that it is Taro Pharmaceuticals USA Inc.
The
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?